adipose tissue remodelling Flashcards
obesity
recognised as one of the most important public health challenges
global obesity prevalence in adults has risen by 2% per decade, currently stands at 13%
small increases in obesity prevalence means millions more people having obesity related diseases
why- primary cause is positive energy balance disrupting energy homeostasis
initial fat accumalates in white adipose tissue and subsequently in other tissues
adipose tissue
comprised of various cell types including mature adipocytes, stromal cells, fibroblasts, macrophages, blood cells, endothelial cells, smooth muscle cells, mesenchymal stem cells and adipocyte pre cursor cells
can cope with excess energy in 2 ways:
- hyperplasia- more cells, occurs through differentiation and proliferation of adipose precursor cells
- hypertrophy- larger cells increase in exisiting adipocyte size
-
hyperplasia
increase in the number of cells in organ/tissue
mesenchymal stem cells are multipotent - differentiate into many cells
an event occurs eg positive energy balance that causes signalling factors that cause some MSCs to commit to becoming APCs
these APCs differentiate and can form brown adipocytes or white adipocytes
hyperplasia in specific fat depot is primarily established in early life and tends to remain stable throughout life (genetically determined)
adipose depots
subcutaneous adipose tissue
visceral adipose tissue
hyperplasia- sex
female- oestrogen impacts appetite, caloric intake and energy expenditure- promotes subcutaneous fat accumlation particularly in gluto femoral eegion, resulting in pear shaped female body
male- testosterone favours the deposition of visceral fat, leading to apple shaped male body
hyperplasia + hypertrophy- age
0-2 years- rapid hypeplasia and hypertrophy
12-18- continued rapid both
adulthood- hyperplasia declines/ stabilises, continued rapid hypertrophy, particularly in visceral depots
hyperplasia age explained
rapid increase in pre adulthood occurs particularly in subcutaneous adipose tissue due to rapid growth hormone, IGF- 1, sex steroids anf nutritiional factors
childhood obesity characterised by acclerated adipose tissue hyperplasia
adipose tissue hyperplasia with obesity
weight stable condition (normal) - 10% annual turonover of adipocytes involving a tightly regulated balance of adipogenesis and adipocyte death
over nutrition (obese)- adipose hyperplasia and increased mass,
- animal models suggest genetic involvement- regulation of hyperplasia by leptin (supresses hunger) plays a large role
adipose hyperplasia- restructrure
replacement of mature adipocyte is acarried out by APC priliferation to new adipocytes, supported by proliferation of other stromal cells to ensure sufficient blood flow to supply oxygen and other nutritents to growing tissue
adipose hyperplasia- number and size
critical to metabolic health; many smaller adipocytes characterised better metabolic status, expressed by higher insulin sensitivity, lower inflammation and less ectopic lipid accumalation
regulators of adipose tissue hyperplasia
centrally- hormones and cytokines regulate satiety/hunger, metabolic and activity states in a complex net of interactions
major central regulators include glucagon peptide 1, neuropeptide Y, leptin, ghrelin and CKK
peripherally- molecular regulators of adipose cell number include insulin, retinoids, corticosteroids and tumour necrosis factor alpha (TNF-a)
hypertrophy
increases adiposity, insulin resistance and inflammation
decreased adipose tissue function
adipose distribution- less subcutenaous fat and more visceral fat
lipid storage- decreased lipid storage capacity, increased in liver and skeletal muscle
adipocyte hypertrophy obesity
occurs most post developmentally in response to over nutrition, is depdendent on the capacity of exisiting adipocytes to capture and retain circulating lipids
during caloric restriction, adipocytes provide nutrients to other tissues through stored lipids and the release of FFAs into circulation
adipose tissue hypertrophy with obesity is complex phenomenom expressed by the increase in size of the individual’s cells and remodelling of adipose tissue
characteristics of hypertrophy
is pro inflammatory
hypoxic- poor vascular expansion as adipocytes expand
dead adipocytes
fibrosis occurs- thickening/scarring
insulin resistant tissue
diminished capacity to store fat
adipose tissue overflow
in responsive state- hypertrophy can reach a plateau that triggers the generation of new adipocytes to accumalate excess fat and reduce spill over to other tissues
in contrast, states of extreme hypertrophic obesity are characterised by reduced hyperplasia and further hypertrophic expansion, accelrating risk of co morbidites
enlarged fat cells have diminished capacity to store fat
meaning fat spill over is directed to non adipose tissue - skeletal muscle, liver and pancreas- whcih accumalte excess toxic fatty acids